Mayer, L., Pandak, W. M., Melmed, G. Y., Hanauer, S. B., Johnson, K., Payne, D., . . . Fischkoff, S. A. (2013). Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study. Inflammatory bowel diseases, 19(4), 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df
Chicago-Zitierstil (17. Ausg.)Mayer, Lloyd, William M. Pandak, Gil Y. Melmed, Stephen B. Hanauer, Kristine Johnson, Denise Payne, Herbert Faleck, Robert J. Hariri, und Steven A. Fischkoff. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases 19, no. 4 (2013): 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df.
MLA-Zitierstil (9. Ausg.)Mayer, Lloyd, et al. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases, vol. 19, no. 4, 2013, pp. 754-760, https://doi.org/10.1097/MIB.0b013e31827f27df.